ABSTRACT
INTRODUCTION
The alveolar epithelium is comprised of two morphologically distinct cell types, cuboidal type II (AT2) cells containing lamellar bodies and located at the corners of the alveolar spaces and large, flattened type I (AT1) cells with expansive cytoplasmic processes that cover the majority of the gas exchange surface of the lung (1, 2) . AT2 cells have been extensively characterized with respect to their roles in surfactant production and active ion transport (3, 4) . In the adult, AT2 cells are also believed to serve as the progenitors for replacement of both AT2 and AT1 cells during normal maintenance and repair of the alveolar epithelium following injury (5, 6) .
Despite the fact that AT1 cells cover the majority of the internal surface area of the lung and play a presumptive role in gas exchange, their functional properties are less well characterized.
With recent improvements in techniques for purification of AT1 cells and immunostaining, evidence is accumulating to support an active role for AT1 cells in aspects of lung function besides gas exchange (7, 8) . For example, recent studies in isolated AT1 cells and AT1 cells in situ demonstrate that AT1 cells express functional Na transport proteins, including Na + ,K + -ATPase, and thereby may contribute to fluid clearance from alveolar spaces (7) .
Due to difficulty in isolating AT1 cells of high yield and purity, AT2 cells grown in culture for several days have been used as a model with which to study AT1-like cell properties. Over a period of 3-4 days, isolated rat AT2 cells gradually lose their characteristic hallmarks, and change morphologically to resemble AT1 cells (9, 10, 11) . Concurrently they acquire a number of phenotypic markers specific for AT1 cells in situ, including aquaporin-5 (AQP5) and T1α/RTI40 (12, 13) , as well as reactivity with the AT1 cell-specific monoclonal antibody (Ab) VIIIB2 (11) , suggesting that these cells are transdifferentiating towards a type I cell-like phenotype (AT1-like cells) resembling the situation in vivo.
While useful for identification of the AT1 cell phenotype, available AT1 cell markers have provided limited insight into AT1 cell functions. Identification of additional AT1 cell genes would be helpful in defining potentially novel AT1 cell functions. To identify candidate type I cell genes of known function, we performed a single microarray analsyis to screen for genes upregulated during transdifferentiation of AT2 cells in primary culture towards an AT1 cell-like phenotype.
We selected eight apparently upregulated genes for further validation (Table 1) 
METHODS

Cell isolation and culture
AT2 cells were isolated from the lungs of adult male Sprague-Dawley rats (150-200 g) by disaggregation with elastase (2.0-2.5 units/ml) (Worthington Biochemical, Lakewood, NJ)
followed by panning on IgG-coated bacteriologic plates as previously described (9, 14) . Enriched AT2 cells were plated in defined serum-free medium onto tissue culture-treated polycarbonate (Nuclepore) filter cups (Transwell; Corning-Costar, Cambridge, MA) at a density of 1x10 6 per cm 2 and grown to confluent high-resistance monolayers (9, 10) . Media were changed on the second day after plating and every other day thereafter. Cells were maintained in a 5% CO 2 incubator at 37 o C. AT2 cell purity (>85%) was assessed by staining freshly isolated cells for lamellar bodies with tannic acid. Cell viability (>95%) was measured by trypan blue dye exclusion.
Mixed alveolar cell populations that included AT1 cells were isolated using several modifications of previously described methods for AT2 and AT1 cell isolation (7, 8, 9, 14) . Briefly, lungs from adult male Sprague-Dawley rats (250-300 g) were perfused via the pulmonary artery with RPMI-1640 containing 25 mM HEPES (solution A). Lungs were lavaged with phosphatebuffered saline (PBS; pH 7.2) containing 5 mM each of EDTA and EGTA, and then filled with 10 ml of solution B (solution A with 5% dextran) containing elastase at 8 U/ml (Worthington) and collagenase (0.1%; Worthington) at 37 o C for a total of 40 min. Lung tissue was dissected away from large airways and chopped in solution B containing 20% fetal bovine serum (FBS) and DNase (3 mg/ml) (Sigma, St Louis, MO). Lung fragments were agitated by end-over-end rotation and filtered sequentially through 100-and 40-µm filters (BD Labware, San Jose, CA) and 20-um Nitex mesh (Tetko, Elmsford, NY). Cytocentrifuged preparations of these mixed alveolar cell populations were processed for IFM.
RNA extraction
Total cellular RNA was extracted from freshly isolated AT2 cells, from AEC at different times in culture, and from whole rat lung by the acid phenol-guanidinium-chloroform method of 
Antibodies
Polyclonal rabbit anti-rat AQP5 and polyclonal rabbit anti-rat P2X4 antibody (Ab) and blocking peptide were from Chemicon (Temecula, CA). Synthetic rat PAI-1 peptide and polyclonal rabbit anti-rat PAI-1 Ab were from American Diagnostics (Greenwich, CT).
Polyclonal rabbit anti-P15 Ab with blocking peptide were from Research Diagnostics (Flanders, NJ). VIIIB2 is a murine monoclonal Ab to rat AT1 cells generated in our laboratory (11) . It recognizes an epitope in the apical membrane of AT1 cells that is not detectable in other rat lung or non-lung cells. MF20, a monoclonal Ab to chicken skeletal muscle myosin heavy chain, was a gift from Don Fischman (Cornell University) and was used as a negative control for VIIIB2 in 
Western blotting
SDS-PAGE was performed using the buffer system of Laemmli (16) and immunoblotting was performed using procedures modified from Towbin et al. (17) . AEC grown on polycarbonate filters for 1 or 8 days were rinsed with cold PBS (pH 7.2) and then solubilized directly into SDS sample buffer (2% SDS, 10% glycerol, 10% β-mercaptoethanol, pH 6.8). Protein concentrations were measured using the DC Protein Analysis System (BioRAD, Hercules, CA). Equal amounts of cell protein in sample buffer were resolved by SDS-PAGE and electrophoretically blotted onto 
Immunofluorescence microscopy (IFM)
All samples for IFM were fixed with 4% paraformaldehyde. For P15 staining, the cells were permeabilized with Tween-20 for 10 min. Concentrations for each of the primary Abs were:
anti-PAI-1 1:100, anti-P2X4 1:100, and anti-P15 1:50. After immunologic reaction (see below), slides were mounted in Vectashield antifade mounting medium with 4',6-diamidino-2-phenylindole (DAPI, blue) or propidium iodide (PI, red) for nuclear staining (Vector). Slides were viewed with an Olympus BX60 microscope equipped with epifluorescence optics. Images were captured separately in monochrome with filters for DAPI, FITC or rhodamine isothiocyanate using a cooled charge-coupled device camera (Magnafire; Olympus, Melville, NY) or with a confocal microscope (Nikon Eclipse, TE 300, Melville, NY) equipped with a Nikon PCM2000 laser scanner and SimplePCI Imaging System 4.0 (Compix, Cranberry Township, PA). For co-localization, monochrome images of the same field were pseudocolored and superimposed on each other.
Images were imported into Adobe Photoshop (Adobe Systems, Mountain View, CA) as TIFF files.
IFM in AEC monolayers
After incubation with CAS block (Zymed, South San Francisco, CA) for 30 min at room temperature, monolayers were incubated at 4°C overnight with primary Abs in CAS, followed by washing with TBS-T. Monolayers were incubated with biotinylated secondary Abs at 1:250 in CAS at room temperature for 45 min, followed by washing with TBS-T. Finally, monolayers were 9 incubated with FITC-conjugated avidin at 1: 400 for 45 min, followed by washing in TBS-T.
Rabbit IgG at the same concentrations as the primary Abs was used as a negative control.
IFM in freshly isolated lung cells
Cytocentrifuged preparations of mixed alveolar cell populations were processed for IFM following fixation in 4% paraformaldehyde. Slides were blocked with CAS for 45 min at room temperature and incubated in primary rabbit Abs, followed by washing with TBS-T. Slides were then incubated with biotinylated secondary anti-rabbit Abs at 1:400. VIIIB2 was mixed with the 
IFM of rat lung sections
Normal rat lung was inflated and fixed in 4% paraformaldehyde following perfusion with PBS to remove red blood cells, and airway lavage to remove macrophages. Lungs were embedded in paraffin and 4 µm thick sections were cut. After deparaffinization and rehydration, the slides underwent microwave antigen retrieval (Antigen Unmasking Solution, Vector). The lungs were processed with Catalyzed Signal Amplification Kit according to the manufacturer's protocol (DAKO, Carpinteria, CA), except in the final step FITC-conjugated avidin replaced alkaline phosphatase-conjugated avidin for signal detection.
RESULTS
Microarray analysis.
We detected changes in the expression of 156 genes in AT1-like cells following transdifferentiation of AT2 cells. Among the genes that were apparently upregulated in AEC on day 8, eight with potential functional relevance to AT1 cell biology were selected for validation and further characterization (Table 1) . Since microarray was performed only once for use as a screening tool, the full microarray analysis is not included here.
RT-PCR and Northern analysis of upregulated genes in AEC. To validate array results by
Northern analysis, we generated cDNA probes by RT-PCR using RNA samples from whole rat lung as template. Using the gene-specific primer pairs listed in Table 1 , we successfully generated cDNA for 7 of the 8 selected genes. Despite its presence on the array, CBLP was not detected by RT-PCR in whole lung RNA, indicating that it is not expressed in significant amounts in lung.
Sequence of the amplified fragments was identical with the published sequences for these genes.
Although KCHNL and ST3 were detected by RT-PCR in whole lung and the identities of the cloned inserts were confirmed by DNA sequencing, neither KCHNL nor ST3 mRNA were detected using these inserts as probes in either AT2 or AT1-like cells by Northern blotting (data not shown). Therefore, in alveolar epithelial cells, ST3 and KCHNL mRNAs appear not to be expressed in significant amounts. Although both BMP4 and ERK1 were detectable by Northern blot in mRNA derived from AEC, changes in expression could not be confirmed by Northern blot.
Levels of expression were similar in AT1-like cells compared to AT2 cells (data not shown),
indicating that expression of these two genes is not changed during the process of transdifferentiation.
Northern blotting confirmed upregulation of mRNA levels of PAI-1, P2X4 and P15 in AT1-like cells (day 8) compared to freshly isolated AT2 cells (day 0) or AEC on day 1 (Fig 1) . (Fig 2) .
PAI-1 was expressed as a doublet of ~40-50 kD, consistent with previous reports of PAI-1 expression in AEC (18, 19) . Representative Western blot (n=3) demonstrates that low levels of PAI-1 protein were present on day 1 but increased markedly in AT1-like cells on day 8 (Fig 2, PAI-1). A positive control using synthesized PAI-1 protein confirmed the size of the PAI-1 protein bands. When PAI-1 Ab was premixed with excessive synthetic PAI-1 peptide, both bands were competed out (data not shown).
P2X4 proteins consist of a 45 kD peptide core and a 65 kD glycosylated form, both of which have been reported in brain and endothelial cells (20, 21) . Representative Western blot (n= 3) demonstrates minimal P2X4 expression on day 1, with clear bands of appropriate sizes in AT1-like cells on day 8 (Fig 2, P2X4 ). Both bands were competed out by pre-incubation of Ab with 5-fold excess blocking peptide (data not shown) demonstrating Ab specificity.
P15 was detected as a single 15 kD band. P15 was detected in AEC on day 1 but, as shown in this representative Western blot (n= 3), levels were much higher in AT1-like cells than AT2 cells (Fig 2, P15) . When the primary antibody was premixed with 5-fold excess blocking peptide, this band was competed out (data not shown), demonstrating Ab specificity.
Localization by IFM in AEC monolayers. Since PAI-1, P2X4 and P15 were all upregulated on day 8 by Western blot, we undertook localization of all three proteins by IFM in AEC on early and late days in monolayer culture. Using this approach, all 3 proteins were present in much higher levels in AT1-like cells on day 8 compared with day 1 (Fig 3) . Due to its intracellular distribution, PAI-1 was detected with a confocal microscope as a punctate cytoplasmic signal (Fig   3, upper panel) . P2X4 was more homogenously distributed, consistent with surface expression of a receptor protein (Fig 3, middle panel) . P15 protein was preferentially distributed in a perinuclear location (Fig 3 lower panel) . Staining patterns were homogenously distributed throughout the monolayer, indicating high purity of cells and homogeneous upregulation of the proteins of interest within the monolayers. (Fig 5) .
Localization of PAI-1, P2X4 and P15 by IFM in freshly isolated
DISCUSSION
We used cDNA array analysis to screen for expression of genes with known function that were upregulated in AEC in primary culture that had transdifferentiated towards an AT1 cell phenotype in order to identify biological properties of AT1 cells (32) . Eight upregulated genes identified in AT1-like cells on day 8 (Table 1) The notion that AT2 cells undergo transdifferentiation towards an AT1-like cell phenotype with time in culture has gained increased acceptance with the demonstration that AT1-like cells express all the known phenotypic markers associated with AT1 cells in situ (9,11,13 14) . AT1 cells have also recently been shown to express functional Na transporters (7, 8) , confirming previous studies in AT1-like cell monolayers. In the current study, we compared patterns of gene expression in freshly isolated AT2 and AT1-like cells after several days in culture in order to identify novel AT1 cell-associated genes of known function. Culture conditions were identical to those used in our previous studies in which AT2 cells were shown to progress towards an AT1-like cell phenotype (9, 11) . Transdifferentiation towards an AT1-like cell phenotype was confirmed by detection of AQP5 expression by Western blot only in AEC on day 8, consistent with our previous studies (9, 11) . Genes identified initially in AT1-like cells were also identified subsequently in AT1 cells.
Using this approach, we identified three different genes of known function that are expressed by 
PAI-1
PAI-1 is a member of the family of serine protease inhibitors (33) . It is the major inhibitor of plasminogen activators in plasma and also within the alveolar space, rapidly inactivating both tissue-type and urokinase-type plasminogen activator through formation of enzymatically inactive complexes (33) . Suppression of fibrinolytic activity within the alveolar spaces has been demonstrated in a number of acute and chronic inflammatory lung disorders, including the acute respiratory distress syndrome and idiopathic pulmonary fibrosis (34, 35, 36) and in animal models of lung injury (27, 37) . PAI-1 is a critical determinant of net fibrinolytic activity within the alveolar space, with local increases in PAI-1 promoting fibrotic repair by inhibiting fibrin degradation (35) . Consistent with this, transgenic mice that are deficient in PAI-1 are protected from both bleomycin and hyperoxic lung injury (27, 37) , while mice that overexpress a PAI-1 transgene develop more extensive fibrosis after bleomycin-induced lung injury (37) . Although alveolar macrophages have been considered the major cellular source of PAI-1 within the alveolar space (22, 23) , AEC have also been shown to synthesize and secrete active PAI-1 in vitro (18, 19) . This differs slightly from the results of Gross et al., in which the increase in PAI-1 activity over time in culture was not accompanied by an increase in mRNA levels (18) . Some of the differences from the previous study may be explained by differences in culture conditions used, since in the current study AEC were maintained in serum-free conditions on polycarbonate filters. Given the large surface area of the lung that is lined by AT1 cells, their contribution to PAI-1 activity within the alveolar space is likely significant and suggests an important role for AT1 cells in regulation of fibrinolytic activity on the alveolar surface under normal conditions and following injury.
P2X4
Purinergic receptors are cell surface molecules that mediate the physiological effects of purine nucleotides (21) . P2X receptors are ATP-gated ion channels that act as Ca 2+ permeable, nonselective cation channels, while P2Y receptors are traditional G protein-coupled receptors that mobilize Ca 2+ from intracellular stores (20, 21, 38) . P2X receptors have a wide tissue distribution, and multiple P2XR channel isoforms, including P2X4, have been identified in airway epithelial cell primary cultures as well as cell lines derived from both airway and alveolar epithelium (20, 38) . P2Y receptors have been identified in AT2 cells, where they are involved in ATPtriggered surfactant secretion (3, 30) . However, no data were available on whether purinergic receptors are also present in AT1 cells. 
